Arcosa Inc (ACA) Stock Analysis
Verdict: WATCH (do not buy)
Infrastructure backlog supports earnings, but stock sits at consensus fair value with stretched forward P/E.
Investment score: 58/100
Analysis as of
Is Arcosa Inc stock worth reviewing? The TradeMates thesis
Arcosa Inc benefits from federal infrastructure backlog and solid operating margins, but at $145.14 the equity trades at full valuation relative to consensus targets ($145.00).
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 75/100 (weight 15%)
- Technical Momentum: 80/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 45/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Arcosa Inc opportunities and risks
What speaks for ACA
- US Federal Infrastructure Spending Backlog
What speaks against ACA
- Full Valuation relative to Analyst Price Targets
Frequently asked questions about Arcosa Inc (ACA)
Is ACA stock a good investment?
The TradeMates model rates Arcosa Inc as WATCH (do not buy) with an investment score of 58/100. Arcosa Inc benefits from federal infrastructure backlog and solid operating margins, but at $145.14 the equity trades at full valuation relative to consensus targets ($145.00). This is algorithmic model output, not personal investment advice.
Is ACA stock a buy?
The TradeMates model verdict for ACA is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.